Genomic trajectory in leukemogenesis of myeloproliferative neoplasms: a case report
Abstract Background We report a patient with Essential Thrombocythemia (ET), subsequently diagnosed with concurrent myeloid and lymphoid leukemia. Generally, the molecular mechanisms underlying leukemic transformation of Philadelphia-negative myeloproliferative neoplasms (Ph-MPN) are poorly understo...
Main Authors: | Yujie Chen, Rafee Talukder, Brian Y. Merritt, Katherine Y. King, Marek Kimmel, Gustavo Rivero, Romina Sosa |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-05-01
|
Series: | BMC Medical Genomics |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12920-021-00986-z |
Similar Items
-
Calreticulin Mutations in Myeloproliferative Neoplasms
by: Noa Lavi
Published: (2014-10-01) -
Aetiology of Myeloproliferative Neoplasms
by: Mary Frances McMullin, et al.
Published: (2020-07-01) -
Molecular biology of Philadelphia-negative myeloproliferative neoplasms
by: Paulo Vidal Campregher, et al.
Published: (2012-01-01) -
Myeloproliferative neoplasm-driving Calr frameshift promotes the development of pulmonary hypertension in mice
by: Keiji Minakawa, et al.
Published: (2021-03-01) -
Thrombotic and hemorrhagic events in 2016 World Health Organization-defined Philadelphia-negative myeloproliferative neoplasm
by: Ik-Chan Song, et al.
Published: (2021-09-01)